Oral Ozempic Delivers Mixed Results on Alcohol Use Semaglutide in pill form shows promise for alcohol use disorder STUDY: Schacht JP et al, American Journal of Psychiatry 2026 STUDY TYPE: Randomized, double-blind, placebo-controlled trial FUNDING: National Institute on Alcohol Abuse and Alcoholism, National Center for Advancing Translational Sciences, Hewit Family Foundation, anonymous donor Background GLP-1 drugs like semaglutide (Ozempic) have a mix of positive and negative data in alcohol use disorder, but most of the research has involved non-treatment seeking populations, which often differ in their responses
View B12 location details Queens 30-07 36th Ave, Astoria, NY 11106 A workday-friendly Queens location for testing when timing and commute matter
Twenty-five percent of us cannot (genetically) clear our bodies of mold toxins, so they damage our gut and cause various symptoms and long-term medical problems
Eur J Epidemiol
The medication works through well-characterized signaling pathways, and adverse events are documented in extensive safety databases